Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01454102 |
|---|---|
| Brief Title: | Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012) |
| First Submitted : | September 16, 2011 |
| First Submitted that Met QC Criteria : | October 17, 2011 |
| First Posted : | October 18, 2011 (Estimate) |
| Results First Submitted : | December 19, 2017 |
| Results First Submitted that Met QC Criteria : | August 2, 2019 |
| Results First Posted : | August 5, 2019 |
| Last Update Submitted that Met QC Criteria : | September 20, 2021 |
| Last Update Posted : | October 12, 2021 |